Clinical Trials Directory

Trials / Completed

CompletedNCT00895193

Alternative Options to Minimize Niacin-Induced Flushing

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Patrick Moriarty, MD, FACP, FACC · Academic / Other
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Niacin (Vitamin B3) is known to effectively and safely treat hypercholesterolemia. However, use of niacin is limited due to incidents of flushing which limits its acceptability. Some information suggests that applesauce can reduce the incidence and severity of flushing. The apple pectin in particular is thought to be the ingredient that affects this reaction. To determine if the apple pectin does affect flushing from niacin, the investigators will study the affects of isolated apple pectin in pill form. The investigators plan on recruiting 100 patients, and giving them 1000 mg of Niacin to induce flushing. Patients will be divided into 4 treatment groups and receive either pectin, aspirin, a combination of both, or placebo. Incidents and severity of flushing will be monitored for up to 6 hours post Niacin ingestion.

Conditions

Interventions

TypeNameDescription
OTHERApple pectinApple pectin 2000mg
DRUGAspirin 325 mgAspirin 325 mg
OTHERPlaceboPlacebo

Timeline

Start date
2009-01-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2009-05-08
Last updated
2014-06-05
Results posted
2014-03-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00895193. Inclusion in this directory is not an endorsement.